of dying from COVID-19, and it is almost certain therefore that the risk/benefit ratio of these vaccines is too great to warrant their use on children.
Misnomer, Misstep and Myocarditis
Myocarditis is a condition caused by inflammation of the heart muscle, and it has been commonly attributed to viruses, drugs or other inflammatory agents. The heart can be mildly to severely affected, causing potential heart failure and arrhythmias. Additionally, it can be an autoimmune process and rogue antigens can precipitate its development. The innate immune system and specific cytokines (Th 17) can be drivers of further destruction. The incidence of myocarditis is uncertain, but it is uncommon and may affect only 1 per 100,000 children.
Truly understanding this rare event in children can be difficult due to diagnostic challenges. It has been postulated that autoimmune myocarditis might be one of the reasons for sudden death reports following the mRNA vaccinations. Unlike other regenerative cells such as liver cells, heart muscle cells do not regenerate.
Long term effects from cardiac inflammation have unpredictable consequences. Of significance, this type of information would have been revealed in a normal vaccine trial.
An awareness for a possible link between the mRNA vaccines and myocarditis started to appear on several fronts beginning in early May. In a statement issued on May 17, 2021, ACIP (the CDC’s Advisory Committee on Immunization Practices) stated that there were relatively few reports of myocarditis, which were more common in males, following the second dose, and symptoms were generally mild.
However, the following week on May 24, 2021, the same committee stated that there was a higher number of observed cases of myocarditis and pericarditis in 16-24 year olds. Two days later, an investigation was launched involving 18 hospitalized vaccinated teens in Connecticut with heart inflammation.
Furthermore, in a multi-organizational report from the journal Pediatrics, seven cases of acute myocarditis/myopericarditis were reported in healthy male teens, all within four days of having received the second dose of the Pfizer vaccine. Six of the 7 boys had no evidence of prior infection with COVID (negative SARS-CoV-2 nucleocapsid antibody assay). Of concern, all the teens had elevated troponin (evidence of ischemic or inflammatory myocardial injury).
They are all reported to have recovered with treatments aimed at inflammation (steroidal and non-steroidal drugs and immune globulin). However, the paper states, “…No causal relationship between vaccine administration and myocarditis has been established. Continued monitoring and reporting to the Food and Drug Administration (FDA) Vaccine Adverse Event Reporting System (VAERS) is strongly recommended.”
As reported by Children’s Health Defense on June 15, 2021, The VAERS database contains 900 cases of myocarditis and pericarditis across all age groups, following COVID vaccines during the time window between Dec. 14, 2020 and June 4, 2021. All but 32 of these cases followed administration of an mRNA vaccine. Sadly, the CHD story showcased a 19-year-old woman who died from heart failure following vaccination.
While the paper cited above denied that a causal relationship between the rare cases of myocarditis and the vaccines had been found, there is considerable literature on both SARS- CoV-2 and on the mRNA vaccines that explains a very plausible causal mechanism.
The mRNA vaccines are made up of many lipid nanoparticles, each of which packages up messenger RNA coding for the spike protein that is normally produced by the virus. The mRNA in the vaccines has been engineered to resist degradation, and also to produce spike protein at a much greater rate than the original virus version does.